Ticker: FATE

Company: FATE THERAPEUTICS INC

Person: Bahram Valamehr, director, officer

Transaction date: Aug. 4, 2026

Reporting date: Aug. 5, 2026

Average share price: 2.4598

Sold 43947.0 shares for 108100.83